TYRO3 and neoplasm: The conclusion that the observed effects of R992 in vivo are predominantly mediated via MERTK are additionally strengthened by the findings that osteoblast-specific deletion of Mertk phenocopies the effects of R992 in the tumor context leading to increased bone mass, while deletion of Tyro3 has the opposite effect.